226 related articles for article (PubMed ID: 11895967)
1. Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.
Flick-Smith HC; Eyles JE; Hebdon R; Waters EL; Beedham RJ; Stagg TJ; Miller J; Alpar HO; Baillie LW; Williamson ED
Infect Immun; 2002 Apr; 70(4):2022-8. PubMed ID: 11895967
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc
Song X; Zhang W; Zhai L; Guo J; Zhao Y; Zhang L; Hu L; Xiong X; Zhou D; Lv M; Yang W
Front Immunol; 2022; 13():819089. PubMed ID: 35154137
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
[TBL] [Abstract][Full Text] [Related]
5. A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge.
Klas SD; Petrie CR; Warwood SJ; Williams MS; Olds CL; Stenz JP; Cheff AM; Hinchcliffe M; Richardson C; Wimer S
Vaccine; 2008 Oct; 26(43):5494-502. PubMed ID: 18703110
[TBL] [Abstract][Full Text] [Related]
6. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR
Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
Huang J; Mikszta JA; Ferriter MS; Jiang G; Harvey NG; Dyas B; Roy CJ; Ulrich RG; Sullivan VJ
Hum Vaccin; 2007; 3(3):90-3. PubMed ID: 17375001
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
[TBL] [Abstract][Full Text] [Related]
9. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.
Mikszta JA; Sullivan VJ; Dean C; Waterston AM; Alarcon JB; Dekker JP; Brittingham JM; Huang J; Hwang CR; Ferriter M; Jiang G; Mar K; Saikh KU; Stiles BG; Roy CJ; Ulrich RG; Harvey NG
J Infect Dis; 2005 Jan; 191(2):278-88. PubMed ID: 15609239
[TBL] [Abstract][Full Text] [Related]
10. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
11. Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.
Malik A; Gupta M; Mani R; Gogoi H; Bhatnagar R
Front Immunol; 2018; 9():562. PubMed ID: 29616046
[TBL] [Abstract][Full Text] [Related]
12. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
[TBL] [Abstract][Full Text] [Related]
13. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.
Zeng M; Xu Q; Pichichero ME
Vaccine; 2007 May; 25(18):3588-94. PubMed ID: 17293013
[TBL] [Abstract][Full Text] [Related]
14. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.
Ramirez K; Ditamo Y; Galen JE; Baillie LW; Pasetti MF
Vaccine; 2010 Aug; 28(37):6065-75. PubMed ID: 20619377
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
[TBL] [Abstract][Full Text] [Related]
16. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
Flick-Smith HC; Waters EL; Walker NJ; Miller J; Stagg AJ; Green M; Williamson ED
Microb Pathog; 2005 Jan; 38(1):33-40. PubMed ID: 15652293
[TBL] [Abstract][Full Text] [Related]
17. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
[TBL] [Abstract][Full Text] [Related]
18. Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.
Chen Z; Schneerson R; Lovchik JA; Dai Z; Kubler-Kielb J; Agulto L; Leppla SH; Purcell RH
Clin Vaccine Immunol; 2015 Aug; 22(8):902-8. PubMed ID: 26041039
[TBL] [Abstract][Full Text] [Related]
19. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
20. Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.
Duc le H; Hong HA; Atkins HS; Flick-Smith HC; Durrani Z; Rijpkema S; Titball RW; Cutting SM
Vaccine; 2007 Jan; 25(2):346-55. PubMed ID: 17007969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
